康宁杰瑞制药-B(09966.HK)盈喜:预期年度转亏为盈逾1.5亿元

格隆汇
04 Mar

格隆汇3月4日丨康宁杰瑞制药-B(09966.HK)发布公告,公司预期将于截至2024年12月31日止年度录得利润不少于人民币150.0百万元,而截至2023年12月31日止年度则录得亏损约人民币210.6百万元。此乃公司首次实现年度盈利。

公司于报告期内转亏为盈,主要基于三项授权合作和销售收入。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10